Literature DB >> 15127191

Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin.

Katy J Fidler1, Peter Wilson, Jane C Davies, Malcolm W Turner, Mark J Peters, Nigel J Klein.   

Abstract

OBJECTIVE: To determine whether pediatric PICU patients with mannose-binding lectin (MBL) gene polymorphisms associated with low levels of the functional protein have an increased risk of developing sepsis and SIRS. DESIGN AND
SETTING: A prospective, observational cohort study in a 22-bed PICU in a tertiary referral centre. PATIENTS: One hundred consecutive admissions to a PICU with at least one organ system failure longer than 12 h. Patients were classified into those with infectious or non-infectious insults as the primary reason for intensive care admission. Patients were followed to determine which developed sepsis or non-infection related SIRS using standard criteria. MEASUREMENTS AND
RESULTS: Of the 100 patients 50 had infectious and 50 had non-infectious insults as the precipitant for admission. 42 patients had variant MBL alleles (determined by MBL-2 gene exon 1 and promoter polymorphisms) and were significantly over-represented amongst the 59 patients that developed SIRS. This effect was not explained by differences in age, sex or ethnicity and was seen in both the infection and non-infection subgroups. In patients with infection, variant MBL alleles were associated with increased systemic response (2/15 with localised infection, 10/19 with sepsis and 12/16 with septic shock). MBL serum levels showed close concordance with the genotype and indicated that MBL levels less than 1000 ng/ml are associated with a greatly increased risk of SIRS.
CONCLUSIONS: MBL-2 exon 1 polymorphisms with low serum levels of functional MBL protein are associated with a greatly increased risk of developing SIRS and of progression from infection to sepsis and septic shock in paediatric ICU patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127191     DOI: 10.1007/s00134-004-2303-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  36 in total

1.  Continuing challenges of sepsis research.

Authors:  M A Crowther; J C Marshall
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

2.  Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.

Authors:  R Mead; D Jack; M Pembrey; L Tyfield; M Turner
Journal:  Lancet       Date:  1997-06-07       Impact factor: 79.321

3.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood.

Authors:  A Koch; M Melbye; P Sørensen; P Homøe; H O Madsen; K Mølbak; C H Hansen; L H Andersen; G W Hahn; P Garred
Journal:  JAMA       Date:  2001-03-14       Impact factor: 56.272

4.  Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series.

Authors:  J A Summerfield; M Sumiya; M Levin; M W Turner
Journal:  BMJ       Date:  1997-04-26

5.  Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease.

Authors:  Peter Garred; Tacjana Pressler; Susanne Lanng; Hans O Madsen; Claus Moser; Inga Laursen; Flemming Balstrup; Claus Koch; Christian Koch
Journal:  Pediatr Pulmonol       Date:  2002-03

6.  Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome.

Authors:  Peter Garred; Jens J Strøm; Lars Quist; Ellen Taaning; Hans O Madsen
Journal:  J Infect Dis       Date:  2003-10-15       Impact factor: 5.226

7.  Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype.

Authors:  R J Lipscombe; M Sumiya; J A Summerfield; M W Turner
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

9.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein.

Authors:  H O Madsen; P Garred; S Thiel; J A Kurtzhals; L U Lamm; L P Ryder; A Svejgaard
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

10.  The human mannose-binding protein functions as an opsonin.

Authors:  M Kuhlman; K Joiner; R A Ezekowitz
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  48 in total

1.  Mannose-binding lectin deficiency provides a genetic basis for the use of SIRS/sepsis definitions in critically ill patients.

Authors:  Joseph A Carcillo
Journal:  Intensive Care Med       Date:  2004-05-06       Impact factor: 17.440

Review 2.  Year in review in intensive care medicine, 2004. III. Outcome, ICU organisation, scoring, quality of life, ethics, psychological problems and communication in the ICU, immunity and hemodynamics during sepsis, pediatric and neonatal critical care, experimental studies.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2005-02-18       Impact factor: 17.440

3.  Searching for the etiology of systemic inflammatory response syndrome: is SIRS occult endotoxemia?

Authors:  Joseph A Carcillo
Journal:  Intensive Care Med       Date:  2006-02-01       Impact factor: 17.440

4.  Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells.

Authors:  Melinda M Dean; Robert L Flower; Damon P Eisen; Robyn M Minchinton; Derek N J Hart; Slavica Vuckovic
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

5.  Mannose-binding lectin and pulmonary morbidity in premature infants.

Authors:  Rachel S Agbeko; Mark J Peters
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

6.  Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis.

Authors:  F N J Frakking; N Brouwer; N K A van Eijkelenburg; M P Merkus; T W Kuijpers; M Offringa; K M Dolman
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

Review 7.  Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment.

Authors:  Michelle Ng Gong
Journal:  Clin Chest Med       Date:  2006-12       Impact factor: 2.878

8.  Angiotensin-converting enzyme D allele does not influence susceptibility to acute hypoxic respiratory failure in children.

Authors:  Adrian Plunkett; Rachel S Agbeko; Kawah Li; Steve E Humphries; Nigel J Klein; Mark J Peters
Journal:  Intensive Care Med       Date:  2008-09-12       Impact factor: 17.440

9.  Mannan-binding lectin is a determinant of survival in infective endocarditis.

Authors:  C T Tran; K Kjeldsen; S Haunsø; N Høiby; H K Johansen; M Christiansen
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

10.  Association of mannose-binding lectin-2 genotype and serum levels with prognosis of sepsis.

Authors:  Jin Won Huh; Kyuyoung Song; Jung-Sun Yum; Sang-Bum Hong; Chae-Man Lim; Younsuck Koh
Journal:  Crit Care       Date:  2009-11-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.